Triage Plus was designed to detect mRNAs and DNA single-nucleotide variants from fibroblast growth factor receptor 3 and telomerase reverse transcriptase genes associated with bladder cancer.
Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced that European Urology Oncology published results of a clinical study demonstrating ...
Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the presentation of a health economics abstract ...
This is an inspection of the bladder and the urethra using a cystoscope. There are two types of cystoscope: Rigid: A solid telescope which has a light and a separate channel to allow other instruments ...
Photocure ASA ( (PHCUF) ) just unveiled an update.
LOS ALTOS, Calif.--(BUSINESS WIRE)--UroViu Corporation announced today that it has received CE certification for its cystoscope and hysteroscope product portfolio. This includes the reusable UV5000w ...
OSLO, Norway, Oct. 15, 2025 /PRNewswire/ -- Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that it has entered into a partnership with Intelligent Scopes Corporation (ISC) to develop ...
Cystoscopy is a test that lets the healthcare provider view the urinary tract. This area includes the bladder, the urethra, and the openings to the ureters. Cystoscopy can help find problems with the ...
In a trial, Xpert® Bladder Cancer Monitor, a non-invasive urinary biomarker test, appeared suitable for guiding cystoscopy during monitoring of patients with NMIBC. Alternating between cystoscopy and ...
When people are suspected to have bladder cancer or have been diagnosed with bladder cancer, their doctors need to inspect the bladder closely and remove tissues for further examination. The removal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback